Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
2 studies found for:    15703418 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Recruiting Collection of Biological Data With Potential Prognostic Relevance in Patients With MYELODYSPLASTIC SYNDROMES
Condition: Myelodysplastic Syndrome
Intervention:
2 Terminated SIMIDIS: Azacitidine and Beta Erythropoietin Treatment in Patients With Myelodysplastic Syndrome
Condition: Myelodysplastic Syndrome
Interventions: Drug: Azacitidine;   Drug: Beta Erythropoietin

Indicates status has not been verified in more than two years